Clinical features of Wegener granulomatosis and microscopic polyangiitis in Chilean patients;Manifestaciones clínicas de la granulomatosis de Wegener y la poliangeítis microscópica en Santiago-Chile, 1990-2001

Revista Medica de Chile

Volumn 133, Issue 3, 2005, Pages 273-278

  Cisternas M, Marcela ^a   Soto S, Lilian ^b,h   Jacobelli G, Sergio ^a   Marinovic M, María Angélica ^c   Vargas B, Alex ^d   Sobarzo V, Elizabeth ^e   Saavedra M, Jorge ^f,h   Chauan I, Karina ^g,h   Meléndez T, Gabriela ^g,h   Foster B, Carolina ^g,h   Pacheco R, Daniel ^c   Wainstein G, Eduardo ^g,i  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^d HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^e HOSPITAL BARROS LUCO TRUDEAU   (Chile)

^f Hospital San Juan de Dios

^g HOSPITAL DEL SALVADOR   (Chile)

^h UNIVERSITY OF CHILE   (Chile)

ⁱ CLÍNICA LAS CONDES   (Chile)

Author keywords

Antibodies, antineutrophil cytoplasmic; Vasculitis; Wegener granulomatosis

Indexed keywords

CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; BLOOD; CHILE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; POLYARTERITIS NODOSA; RETROSPECTIVE STUDY; REVIEW; SEX RATIO; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILE; CREATININE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYARTERITIS NODOSA; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; WEGENER GRANULOMATOSIS;

EID: 30844455823     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. GONZÁLEZ-GAY M, GARCÍA-PORRÚA C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729-49.
2. GONZÁLEZ-GAY M, GARCÍA-PORRÚA C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine 1999; 78: 292-308.
3. COTCH M, HOFFMAN G, YERG D, KAUFMAN G, TARGONSKI P, KASLOW R. The epidemiology of Wegener's granulomatosis. Estimates of the five year prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis rheum 1996; 39: 87-92.
4. KOLDINGSNES W, NOSSENT H. Epidemiology of Wegener's granulomatosis in Northern norway. Arthritis Rheum 2000; 43: 2481-7.
5. WATTS R, LANE S, BENTHAM G, SCOTT D. Epidemiology of systemic vasculitis. A ten-year study in the United Kingdom. Arthritis Rheum 2000; 43: 414-9.
6. HOFFMAN G, KERR G, LEAVITT R, HALLAGAN C, LEVOBICS R, TRAVIS W ET AL. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
7. JENNETTE C, FALK R, ANDRASSY K, BACON P, CHURG J, GROSS W ET AL. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
8. GIRARD T, MAHR A, NOËL LH, CORDIER JF, LESAVRE P, ANDRÉ MH ET AL. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in wegener's granulomatosis? A prospective study. Rheumatology 2001; 40: 147-51.
9. HOGAN S, NACHMAN P, WILKMAN A, JENNETTE C, FALK R. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32.
10. GUILLEVIN L, LHOTE F. Treatment of polyarteritis nodosa and microscopic polyangeiitis. Arthritis Rheum 1998; 41: 2100-5.
11. SCOTT D, WATTS R. Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 2000; 59: 161-3.
12. GONZÁLEZ-GAY MA, GARCÍA-PORRUA C, GUERRERO J, RODRÍGUEZ-LEDO P, LLORCA J. The epidemiology of the primary systemic vasculitides in Northwest Spain: implications of the Chappel Hill consensus conference definitions. Arthritis Rheum 2003; 49: 388-93.
13. CSERNOK E. Anti-neutrophil cytoplasm antybodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003; 2: 158-64.
14. PRADHAN VD, BADAKERE S, IYER YS, KUMAR RR, ALMEIDA AF. A study of antineutrophil cytoplasm antibodies in systemic vasculitis and other related disorders. J Postgrad Med 2003; 49: 5-9.
15. RUTGERS A, HEERINGA D, DAMOISEAUX JG, COHEN JW. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitis disease. Eur J Intern Med 2003; 14: 287-95.
16. RAO J, ALLEN N, FEUSSNER J, WEINBERGER M. A prospective study of antineutrophil cytoplasmatic antibody (cANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 346: 926-31.
17. MAHR A, GIRARD T, AGHER R, GUILLEVIN L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology 2001; 40: 492-8.
18. GUILLEVIN L, DURAND-GASSELIN B, CEVALLOS R, GAYRAUD M, LHOTE F, CALLARD P ET AL. Microscopic polyangiitis. Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30.
19. LAUQUE D, CADRANEL J, LAZOR R, POURRAT J, RONCO P, GUILLEVIN L ET AL. Microscopic polyangeiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine 2000; 79: 222-33.
20. SPECKS U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001; 13: 12-7.
21. TIDMAN M, OLANDER R, SVALANDER C, DANIELSSON D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244: 133-41.